drugset / Trial / NCT02493504

Effects of Heparin on Arteriovenous Fistula Patency

NCT02493504

Phase 4 Completed 150 enrolled Fatemeh Hoseinzadegan
RandomizedParallel-groupOpen-labelPrevention

Summary

Arteriovenous fistula (AVF) is now the optimal method of obtaining vascular access for dialysis. Measures such as systemic anticoagulation have been proposed as means of increasing patency rates but enough evidence does not exist to support their use. The investigators aimed to evaluate the efficacy of preoperative heparin injection on patency of AVF during the first 24 hours after surgery and to determine whether such measure can be used to prevent early thrombosis of the vascular access.

Timeline

Start
2011-01
Primary completion
2012-04
Completion
2013-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 100 iu/kg